SAKAR HEALTHCARE
Back to Balance Sheet
|
SAKAR HEALTHCARE Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹67 Cr | ₹67 Cr | ₹108 Cr | ₹94 Cr | ₹46 Cr |
What is the latest Total Non-Current Liabilities ratio of SAKAR HEALTHCARE ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹67 Cr |
| Mar2024 | ₹67 Cr |
| Mar2023 | ₹108 Cr |
| Mar2022 | ₹94 Cr |
| Mar2021 | ₹46 Cr |
How is Total Non-Current Liabilities of SAKAR HEALTHCARE Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹67 Cr | -0.99 | |
| Mar2024 | ₹67 Cr | -38.00 | |
| Mar2023 | ₹108 Cr | 15.99 | |
| Mar2022 | ₹94 Cr | 103.03 | |
| Mar2021 | ₹46 Cr | - | |
Compare Total Non-Current Liabilities of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹1,776.8 Cr | -5.7% | -1.6% | 129% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,195.0 Cr | 1.8% | 9% | 12.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,823.0 Cr | 0.8% | 0.8% | -1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,725.0 Cr | 2.8% | 9.5% | 45.4% | Stock Analytics | |
| CIPLA | ₹116,467.0 Cr | -1.2% | 4.7% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,987.0 Cr | -7.6% | 0.1% | 6.1% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | -5.7% |
-1.6% |
129% |
| SENSEX | -1% |
4.4% |
-8.3% |
You may also like the below Video Courses